Physician

Jennifer Marie Porta, D.O

According to 2025 Medicare claims, Jennifer Porta, D.O (NPI: 1699209478) practices hematology/oncology in the Fayetteville-Springdale-Rogers, AR market, with the plurality of this provider's patient population coming from Washington, AR. This provider's primary affiliated billing organization is HIGHLANDS ONCOLOGY GROUP PA (NPI: 1346211323; TIN: 710788742) and primary practice location at 72758-8602. Porta is affiliated with the Mercy Health ACO, LLC (ACO ID: A2616), participating under the MSSP model.

Porta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,194 traditional Medicare patients, billed 201,091 HCPCS/CPT codes, and received $3,116,810 in Medicare payments. The top billing code was 80053 (Blood test, comprehensive group of blood chemicals). Part D data shows 1,220 prescription claims across 282 beneficiaries totaling $790,981 in drug costs, led by Verzenio (Abemaciclib). DME data shows 11 claims. Open Payments data shows 30 records totaling $562. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,749 to $790,981. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.6M$3.1M2023 Medicare payment: $957,340 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,116,810 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
202340466,058$957,340
20241,194201,091$3,116,810

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$395K$791K2018 Drug cost: $1,749 (USD; Tot_Drug_Cst)2019 Drug cost: $409 (USD; Tot_Drug_Cst)2020 Drug cost: $1,323 (USD; Tot_Drug_Cst)2021 Drug cost: $4,684 (USD; Tot_Drug_Cst)2023 Drug cost: $171,294 (USD; Tot_Drug_Cst)2024 Drug cost: $790,981 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20182045$1,749
2019N/R22$409
2020N/R39$1,323
2021N/R20$4,684
2022N/RN/RN/R
202393204$171,294
20242821,220$790,981

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$104$2072024 Medicare payment: $207 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/R11$207

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
80053Blood test, comprehensive group of blood chemicals5261,137$10
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count5591,290$8
83735Magnesium level5091,098$7
82248Bilirubin level, direct5071,089$5
84550Uric acid level, blood5071,089$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VerzenioAbemaciclib17476$255,641
JakafiRuxolitinib Phosphate11330$189,924
EliquisApixaban24820$15,783
XareltoRivaroxaban15540$9,043
AnastrozoleAnastrozole23813,383$3,507

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
K0001Standard wheelchairYN/R11$207

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.30$562Daiichi Sankyo Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jennifer Marie Porta, D.O?

Tedicare shows public-source Medicare data for Jennifer Marie Porta, D.O (NPI 1699209478), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jennifer Marie Porta, D.O have ACO affiliation data?

Jennifer Marie Porta, D.O is shown with ACO affiliation data for Mercy Health ACO, LLC (MSSP, ACO ID A2616).

What billing organization is linked to Jennifer Marie Porta, D.O?

Jennifer Marie Porta, D.O is linked to HIGHLANDS ONCOLOGY GROUP PA (billing NPI 1346211323) in the available physician profile data.

Does Jennifer Marie Porta, D.O have Open Payments data?

Jennifer Marie Porta, D.O has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.